iScience 19 , 11331144 (2019)
As per Lilly 2024 financial results the drug had reported worldwide annual sales of more than $16 billion$11.5 billion (Mounjaro) and $4.96 billion (Zepbound)
Based on announcements in early 2026, the FDA and HHS signaled reclassifying a group of peptides, including BPC-157, TB-500, and injectable GHK-Cu, toward Category 1, which makes them eligible for use by licensed compounding pharmacies preparing individualized medications under a prescription
For acute pain crises, cortisone may be more practical
Accessibility issues: With the popularity of weight loss medications today, people may struggle to refill their prescriptions and receive them on time because of widespread shortages, high demand exceeding supply and limited availability at pharmacies